Meeting
2016 ASCO Annual Meeting
Predicted benefit of alternative post-treatment surveillance strategies in stage II and III colon cancer survivors.
Authors
Johnie Rose
Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
Johnie Rose , Laura Homa , Chung Yin Kong , Gregory S. Cooper , Michael W. Kattan , Neal J. Meropol
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Other Colorectal and Anal Cancer
Citation
J Clin Oncol 34, 2016 (suppl; abstr 3623)
DOI
10.1200/JCO.2016.34.15_suppl.3623
Abstract #
3623
Poster Bd #
320
Abstract Disclosures
Similar Posters
First Author: Lucy Gately
Poster
2024 ASCO Annual Meeting
Survival and patient-reported outcomes of real-world patients with high-risk stage II and stage III colon cancer after 3 versus 6 months of adjuvant CAPOX.
First Author: Ingrid A. Franken
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Predicting recurrence in patients with stage II and III colon cancer: Validation cohort and long-term follow-up of the experimental cohort.
First Author: David Viñal
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic value of tumor budding in patients with stage II and III colon cancer: A single-institution experience.
First Author: David Viñal